BDSB.F
Last
- - (-%)Time
-Previous Close
-
Open
-High
-Low
-
Latest News
Roche’s fenebrutinib significantly reduced relapses versus standard of care to approximately one every 17 years in RMS
published on April 21, 2026, 11:15 pm (via GlobeNewswire)
Related Stocks
Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.